Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.

Congressional candidate physician sues hospital and doctor for death of father
Some of the claims in the lawsuit, brought against Novant Health by Kyle Horton, MD, are backed by a report from the North Carolina Department of Health and Human Services.
Diabetes reduces survival after SAVR, but not TAVR
"TAVR has been associated with better valve hemodynamics and a lower risk of structural valve deterioration over time compared with SAVR," researchers wrote. "This benefit may be particularly relevant for diabetes patients who face higher risks of vascular complications."
DEA wants to permanently anchor some COVID-era prescription regulations
The Drug Enforcement Administration is proposing the adoption of some COVID-era prescription practices around certain controlled substances. The agency published a framework to guide any such changes Jan. 17.
Brain changes related to Huntington's evident on imaging decades before symptoms emerge
Experts hope their findings offer valuable insights that one day lead to improved interventions aimed at preserving brain function in patients with Huntington's.
Medtronic heart rhythm technologies on full display at AF Symposium 2025
Cardiologists shared updated data on Medtronic's ICM and PFA offerings during AF Symposium 2025 in Boston.

Catheter-based heart failure treatment gains breakthrough device designation

preCARDIA announced that its catheter-based system for acutely decompensated heart failure has received the FDA’s breakthrough device designation.

Protamine administration during transcatheter aortic valve replacement (TAVR) is associated with a significant reduction in life-threatening and major bleeding complications.

Cardiologists shed new light on COVID-19 and cardiac arrhythmias

A higher rate of cardiac arrhythmias has been observed in hospitalized COVID-19 patients, but new research suggests there’s more behind that trend than the virus itself.

Protein boosts heart attack recovery, could be a game-changer for patients

There are approximately 20,000 proteins in the human heart—and one of them, if administered as a drug, could help patients recover more quickly following a myocardial infarction.

CMS forms independent commission for COVID-19 response in nursing homes

CMS has announced the members of the independent Coronavirus Commission on Safety and Quality in Nursing Homes, as the agency is seeking an independent review and assessment of what happened at nursing homes across the countries when COVID-19 hit.

FDA approves new fast-acting insulin for type 1 and type 2 diabetes

The approval was based on data from two phase III randomized, treat-to-target studies.

Hospitals are already treating COVID-19 patients with common steroid

Hospitals in the U.S. are already using dexamethasone, a commonly known steroid that’s readily available and inexpensive, to treat COVID-19 patients without waiting for confirmation of preliminary results from a British study that found the drug can greatly improve survival.

Infective endocarditis after TAVR: 4 key findings from a new study of 7,000 patients

Infective endocarditis is a relatively rare complication of TAVR, but the infection can be fatal when it does strike.

Clinical

Congressional candidate physician sues hospital and doctor for death of father

Diabetes reduces survival after SAVR, but not TAVR

DEA wants to permanently anchor some COVID-era prescription regulations

Brain changes related to Huntington's evident on imaging decades before symptoms emerge

Medtronic heart rhythm technologies on full display at AF Symposium 2025